Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

MAb Aggregate Removal through IEC in Bind/Elute and Flow-Through Mode

Purification schemes for monoclonal antibodies typically consist of three chromatographic steps accompanied by filtration steps. The common Protein A capturing is typically followed by ion exchange (IEC), hydrophobic interaction (HIC) or mixed-mode polishing steps. Residual DNA, viruses, and host cell proteins are usually removed by flow-through anion exchange chromatography while aggregates can be reduced through a cation exchange, mixed-mode, or HIC step.

The salt tolerant anion exchange resin TOYOPEARL NH2-750F provides a unique selectivity compared to other anion exchange resins and was found to be suited for aggregate removal, too. Herein we describe the development of an anion exchange polishing step for the purification of a monoclonal antibody by using TOYOPEARL NH2-750F. In general, anion exchange resins can be used in bind and elute (B/E) mode as well as in flow-through (FT) mode. Both options were evaluated. To increase the amount of aggregates of the test sample, a monoclonal antibody was aggregated by acidic incubation and subsequently diluted to 1 g/L in loading buffer.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Related White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

A Fast and High Precision Influenza Vaccine Potency Assay

| Contributed by ForteBio

MDRS used to confirm the pharmaceutical equivalence of Oral Solid Dose (OSD) products

| Contributed by Malvern Panalytical

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register